Bożena Sosnowska

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 7

This page only lists publications with an associated author ORCID identifier.

Publications

Bożena Sosnowska, Stanisław Surma, Maciej Banach
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Bożena Sosnowska, Weronika Adach, Stanislaw Surma, Robert S Rosenson, Maciej Banach
Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. Journal of clinical medicine 12 (1) (2022)
Bożena Sosnowska, Stanisław Surma, Maciej Banach
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Bożena Sosnowska, Weronika Adach, Stanislaw Surma, Robert S Rosenson, Maciej Banach
Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. Journal of clinical medicine 12 (1) (2022)
Bożena Sosnowska, Stanisław Surma, Maciej Banach
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Bożena Sosnowska, Stanisław Surma, Maciej Banach
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Bożena Sosnowska, Weronika Adach, Stanislaw Surma, Robert S Rosenson, Maciej Banach
Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. Journal of clinical medicine 12 (1) (2022)